Endometriosis

Women's health company seeks to raise $15M; begins phase II trials

Published in Women's Health Weekly, September 5th, 2002

FemmePharma, Inc.'s, lead drug for the treatment of endometriosis is currently being studied in a nationwide phase II clinical trial with one center in the Chicago area.

FemmePharma, based in Wayne, Pennsylvania, a Philadelphia suburb, was founded in 1996 by CEO Gerianne Tringali DiPiano. DiPiano approached investors with her plan to form a pharmaceutical company devoted to women's unmet health needs.

According to DiPiano, "Drug companies assume that their products have equal applicability to men and women, despite inherent physiological differences between the sexes." DiPiano estimates the women's healthcare segment to be a $35 billion...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-09-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry